Aim: This study investigated whether post-partum insulin resistance existed in women with a history of severe pre-eclampsia.
Methods: The euglycemic hyperinsulinemic clamp technique was used to assess insulin sensitivity at least 6 months after delivery in 13 women who had had severe pre-eclampsia and 26 age- and body mass index-matched controls who had had normal pregnancy.
Results: The mean (+/-SD) durations after delivery were 2.6 +/- 1.6 years and 4.5 +/- 2.8 years in the pre-eclampsia and control groups, respectively. The systolic blood pressure was significantly higher in the pre-eclampsia group (118 +/- 11 mmHg vs 109 +/- 12 mmHg, P = 0.028). Although the body mass indices were not different among the groups (25.8 +/- 3.1 kg/m(2) vs 24.6 +/- 3.9 kg/m(2)), the waist and waist-to-hip ratio were significantly higher in the women with prior pre-eclampsia. The pre-eclampsia group had lower insulin sensitivity index than the controls (5.4 +/- 2.5 mg/kg/min/mU/L vs 8.1 +/- 4.0 mg/kg/min/mU/L, P = 0.036). Serum triglyceride levels were significantly higher in the pre-eclampsia group (153 +/- 74 mg/dL vs 82 +/- 37 mg/dL, P < 0.01). High-density lipoprotein-cholesterol levels tended to be lower in the pre-eclampsia group (42.1 +/- 9.7 mg/dL vs 48.2 +/- 9.6 mg/dL, P = 0.07).
Conclusion: Women with a history of severe pre-eclampsia had characteristics of metabolic syndrome and had lower insulin sensitivity compared with those who had had normal pregnancy. These may explain an increased risk of cardiovascular disease in women with pre-eclampsia.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1447-0756.2008.00865.x | DOI Listing |
BMC Pregnancy Childbirth
January 2025
The Department of Obstetrics, Obstetrics and Gynecology Hospital of Fudan University, 419 Fangxie Road, Huangpu Area, Shanghai, 200011, China.
Background: The objective of this study was to investigate the efficacy of low-dose aspirin (LDA) in preventing preeclampsia among pregnant women with polycystic ovary syndrome (PCOS), given the increased susceptibility of this population to preeclampsia development.
Methods: A retrospective cohort study was conducted on pregnant women with PCOS who delivered between January 1, 2018 and February 10, 2024 at our institution. Clinical characteristics and obstetric data were extracted from medical records.
J Clin Hypertens (Greenwich)
January 2025
Department of Obstetrics and Gynecology, Women and Children's Hospital of Chongqing Medical University, Chongqing, China.
Hemolysis, elevated liver enzymes, low platelet count (HELLP) syndrome is a severe complication of preeclampsia (PE), with a higher incidence rate in people living at high altitudes, such as Tibet area. Maternal HELLP syndrome is associated with an elevated neonatal mortality rate. The purpose of this study was to investigate the predicting factors for neonatal outcomes with maternal HELLP syndrome.
View Article and Find Full Text PDFNiger Med J
January 2025
Department of Internal Medicine, Federal Medical Centre, Yenagoa, Bayelsa State, Nigeria.
Background: The prevalence of gestational diabetes mellitus (GDM) is dependent on the diagnostic criteria used and there is no consensus on screening methods and diagnostic criteria. The International Association for Diabetes in Pregnancy Study Group (IADPSG) recently put forward new diagnostic criteria and encourages its adoption worldwide. The aim of this study was to determine the incidence of GDM and to compare the foeto-maternal outcomes of women diagnosed with GDM in the Federal Medical Centre, Yenagoa using the WHO 1999 and IADPSG criteria.
View Article and Find Full Text PDFJAMA Netw Open
January 2025
Magee-Womens Research Institute, Department of Obstetrics, Gynecology and Reproductive Sciences, Epidemiology and Clinical and Translational Research, University of Pittsburgh, Pittsburgh, Pennsylvania.
Importance: Chronic hypertension and preeclampsia are leading risk enhancers for maternal-neonatal morbidity and mortality. Severe maternal morbidity (SMM) indicators include heart, kidney, and liver disease, but studies have not excluded patients with preexisting diseases that define SMM. Thus, SMM risks for uncomplicated chronic hypertension specific to preeclampsia remain unclear.
View Article and Find Full Text PDFBMC Pregnancy Childbirth
January 2025
Department of Gynecology and Obstetrics, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China.
Aim: Our study aimed to evaluate the predictive value of Placental growth factor (PlGF), Vitamin D, and systemic inflammatory index for assessing preeclampsia risk and severity.
Materials And Methods: This retrospective cohort study included 457 pregnant individuals who delivered at our hospital between March 2023 and October 2024. Participants were divided into three groups: control (n = 217), mild preeclampsia (n = 101), and severe preeclampsia (n = 67).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!